李氏大药厂(00950.HK)根据购股权计划授出176.4万股股份
Core Viewpoint - Lee's Pharmaceutical Holdings Limited (00950.HK) announced the granting of stock options to several eligible participants under the stock option plan adopted on May 19, 2022, which allows for the subscription of a total of 1.764 million ordinary shares of the company [1] Group 1 - The stock options will be granted on October 15, 2025 [1] - The total number of shares available for subscription through the stock options is 1.764 million [1]